Genes selected for Myriad myRisk™ satisfy these criteria:
- Cancer Focus
- Hereditable contribution
- Association with overlapping syndromes
- Cancer risk is at least 2-3 times the general population
- Clinically Significant
- Based on increased cancer risk from societal guidelines or determined by multiple studies
- Change in management inferred based on risk level
Each gene tested with Myriad myRisk links to one or more of eight cancer sites: Breast, Ovarian, Colorectal, Endometrial, Melanoma, Pancreatic, Gastric, and Prostate.
Myriad myRisk simplifies the test selection process by providing you the most comprehensive hereditary cancer panel test with clinically significant results. Be confident you are testing for the primary clinically significant genes associated with your patients’ risk.
To learn more about myRisk genes and associated syndrome please click here